Fennec Pharmaceuticals CMO Sayad Sargis Sells 12,000 Shares

What Happened Sayad Pierre Sargis, Chief Medical Officer of Fennec Pharmaceuticals (FENC), sold 12,000 shares in an open-market/private sale on August 31, 2026, at $12.18 per share for total proceeds of $146,160. On the same date he was credited with 168 shares at $0.00 representing restricted shares released from an award. The sale is a disposition of previously vested restricted shares and vested performance shares.

Key Details

• Transaction date: 2026-08-31
• Sale: 12,000 shares disposed at $12.18 each — proceeds $146,160 (footnote F2: sale of previously vested restricted and performance shares)
• Acquisition: 168 shares acquired at $0.00 (footnote F1: shares released from restriction from award dated 2025-03-28)
• Shares owned after transaction: not specified in the Form 4 filing
• Filing timeliness: no late filing indicated in the report

Context Sales of vested or released restricted shares are commonly routine (tax withholding, diversification, or personal liquidity) and do not necessarily indicate a change in the insider’s view of the company. The acquisition here reflects shares released from prior awards rather than a cash purchase; purchases typically carry more weight as a bullish signal.